Evelo Biosciences, Inc.
EVLO
$0.0003
-$0.0002-40.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.26M | 7.62M | 27.47M | 47.94M | 69.05M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.67M | 3.64M | 2.61M | 3.63M | 3.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 18.94M | 11.26M | 30.08M | 51.57M | 72.33M |
|
|
|||||
| Total Current Assets | 18.94M | 11.26M | 30.08M | 51.57M | 72.33M |
| Net Property, Plant & Equipment | 894.00K | 8.13M | 10.73M | 11.71M | 12.85M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 797.00K | 1.42M | 1.16M | 1.16M | 1.16M |
| Total Assets | 20.63M | 20.82M | 41.97M | 64.44M | 86.34M |
|
|
|||||
| Total Accounts Payable | 526.00K | 3.77M | 1.51M | 1.76M | 1.55M |
| Total Accrued Expenses | 4.55M | 5.15M | 9.51M | 7.95M | 12.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 33.95M | 46.61M | 46.12M | 2.26M | 12.27M |
| Total Finance Division Other Current Liabilities | 737.00K | 20.00K | 110.00K | 427.00K | 617.00K |
| Total Other Current Liabilities | 737.00K | 20.00K | 110.00K | 427.00K | 617.00K |
| Total Current Liabilities | 39.76M | 55.54M | 57.25M | 12.40M | 26.92M |
|
|
|||||
| Total Current Liabilities | 39.76M | 55.54M | 57.25M | 12.40M | 26.92M |
| Long-Term Debt | -- | -- | -- | 43.61M | 36.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 3.88M | 4.58M | 5.27M | 5.94M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.57M | 7.53M | 7.53M | 8.16M | 7.50M |
| Total Liabilities | 47.33M | 66.95M | 69.36M | 69.43M | 77.00M |
|
|
|||||
| Common Stock & APIC | 561.32M | 529.54M | 527.18M | 524.23M | 515.02M |
| Retained Earnings | -588.03M | -575.67M | -554.56M | -529.22M | -505.68M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -26.71M | -46.13M | -27.39M | -4.99M | 9.33M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -26.71M | -46.13M | -27.39M | -4.99M | 9.33M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -26.71M | -46.13M | -27.39M | -4.99M | 9.33M |
|
|
|||||